logo

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

GlaxoSmithKline Share Price

GLAXO

2,930

27.80(0.96%)
24th Aug 2026 | 3:28 PM
NSE : GLAXO
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

GlaxoSmithKline Performance

Price Movement

₹2930.00

₹2865.40

₹2955.90

Today's LowToday's High

1 Year Performance

₹2930.00

₹2088.10

₹3054.90

52 Week Low52 Week High

Markets Today

High₹2,955.90
Low₹2,865.40
Open at₹2,875.10
Prev Close₹2,902.20
Volumes80.14 K
Avg Price₹2,923.06
Lower Circuit₹2,321.80
Upper Circuit₹3,482.60

Historical Performance

3M High₹3,054.90
3M Low₹2,088.10
1 Yr High₹3,054.90
1 Yr Low₹2,088.10
3 Yr High₹3,515.70
3 Yr Low₹1,385.05
5 Yr High₹3,515.70
5 Yr Low₹1,227.00

Summary

As of 25-08-2026 01:25, GlaxoSmithKline Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-2902.20 (-100.00%) from the previous close of ₹2902.2. The stock opened at ₹2875.1 and traded between ₹2865.4 and ₹2955.9, with a total traded volume of 80140 shares. The company has a market capitalization of ₹49165 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3054.9 and ₹2088.1, respectively.

GlaxoSmithKline Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 46, EPS of ₹61.15, and book value of ₹19.60. Profitability indicators show ROE of 45.68% along with a dividend yield of 2%. GlaxoSmithKline Pharmaceuticals Ltd. has reported revenue of ₹3954.94 Cr and net profit of ₹1068.15 Cr.

GlaxoSmithKline Pharmaceuticals Ltd. technical indicators include Day RSI at 68.85, Day MFI at 90.8, Day ADX at 39.43. Additional indicators include Commodity Channel Index (CCI) at 157.5 and Williams %R at -28.28. Momentum indicators show Day MACD at 113.99, Day MACD Signal Line at 83.75, DayATR at 85.81. Rate of Change indicators for GlaxoSmithKline Pharmaceuticals Ltd. include ROC125 at 11.47 and ROC21 at 16.32.

Exponential moving averages include EMA5 at ₹2894.1, EMA10 at ₹2812.7, EMA12 at ₹2788.3, EMA20 at ₹2715.1, EMA26 at ₹2674.3, EMA50 at ₹2571.8, EMA100 at ₹2502.4, EMA200 at ₹2510.2. Simple moving averages include SMA5 at ₹2902.9, SMA10 at ₹2769.4, SMA20 at ₹2691.4, SMA30 at ₹2623.6, SMA50 at ₹2512.3, SMA100 at ₹2427.7, SMA150 at ₹2440.9, SMA200 at ₹2459.9.

Support levels for GlaxoSmithKline are placed at First Support ₹2858.33, Second Support ₹2814.47, Third Support ₹2748.93. Resistance levels are seen at First Resistance ₹2967.73, Second Resistance ₹3033.27, Third Resistance ₹3077.13. GlaxoSmithKline Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 4.79%, DII holding at 0%, public holding at 12.42%.

GlaxoSmithKline Fundamentals

Market Cap
High in industry
49,165 Cr.
PE Ratio (TTM)
Above industry Median
46
Dividend Yield
High in industry
2
Net Profit TTM
12.4% incr over last year
1,068.15
Net Profit Growth
12.4% incr over last year
1,068.15
PEG Ratio
High in industry
3.70
ROE
4% decr over last year
45.68
Operating Revenue TTM
3,954.94
Operating Revenue Growth
5.8% incr over last year
Book Value
High in industry
19.60
MFI
MFI strongly Overbought
90.80
RSI
RSI is mid-range
68.85
EPS (TTM)
61.15
Debt to Equity
0
Face Value
10
Operating Profit Margin Qtr.
33
Operating Profit Qtr.
295.50
Net Profit Qtr.
237.18
Operating Revenue Qtr.
938.44
PB Ratio
19.60

GlaxoSmithKline Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Total Revenue924.42989.151,022.59973.63804.83
Operating Expense631.26641.96655.01638.95554.08
Operating Profit293.16347.19367.58334.68250.75
Depreciation15.8413.1720.3217.4315.52
Interest0.970.611.190.510.42
Tax84.6594.18100.7195.6573.87
Net Profit253.33274.94277.18255204.70

GlaxoSmithKline Technicals

GlaxoSmithKline Pharmaceuticals Ltd. EMA & SMA

2930.00

-69.70 (-2.32%)

Bullish Moving Average

15

Bearish Moving Average

1

Day EMA5 ₹2894.1
Day EMA10 ₹2812.7
Day EMA12 ₹2788.3
Day EMA20 ₹2715.1
Day EMA26 ₹2674.3
Day EMA50 ₹2571.8
Day EMA100 ₹2502.4
Day EMA200 ₹2510.2

GlaxoSmithKline Support and Resistance

Resistance

First Resistance₹2967.73
Second Resistance₹3033.27
Third Resistance₹3077.13

Support

First Support₹2858.33
Second Support₹2814.47
Third Support₹2748.93

Technical Indicators

Day RSI68.85
Day MFI90.80
Day ADX39.43
Day Commodity Channel Index157.50
William-28.28
Day MACD113.99
Day MACD Signal Line83.75
Day ATR85.81
Day ROC12511.47
Day ROC2116.32

GlaxoSmithKline Shareholding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter757575757575
FII4.54.954.64.64.8
DII7.87.787.77.77.8
Public12.712.41212.712.712.4

GlaxoSmithKline Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day39.55 K93.13 K42.47%
Week2.11 L4.95 L42.62%
1 Month79.41 K1.67 L47.59%
6 Month66.33 K1.14 L58.29%

GlaxoSmithKline SWOT Analysis

Strengths20
Weakness10
Opportunity5
Threats2

Companies with no Debt

Benjamin Graham Value Screen

Expensive Stars (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

GlaxoSmithKline Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
29 May, 202657FINAL29 May, 2026Equity Share
30 May, 202542FINAL30 May, 2025Equity Share
07 Nov, 202412INTERIM07 Nov, 2024Equity Share
31 May, 202432FINAL31 May, 2024Equity Share
30 Jun, 202332FINAL30 Jun, 2023Equity Share
07 Jul, 202260SPECIAL08 Jul, 2022Equity Share
07 Jul, 202230FINAL08 Jul, 2022Equity Share
19 Jul, 202130FINAL20 Jul, 2021Equity Share
17 Jul, 202020SPECIAL20 Jul, 2020Equity Share
17 Jul, 202020FINAL20 Jul, 2020Equity Share

GlaxoSmithKline Stock Comparison

Financials
Price (₹)₹1,766₹883.60₹1,436.80₹1,862₹2,374.50₹212.43
% Change2.39%1.39%-1.41%-0.05%-0.40%-0.58%
Revenue TTM (₹ Cr)₹1,935.80₹2,002.34₹2,250.36₹9,683.45₹14,737.88₹9,205.28
Net Profit TTM (₹ Cr)₹288.22₹575.94₹361.74₹1,011.39₹2,042.67₹-313.62
PE TTM99.1085.2085.5034.9048.20-90.70
1 Year Return255.615.957.424.77-8.5510.85
ROCE24.3227.5618.3825.6514.322.29

FAQ's on GLAXO

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy